நிறுவனம் அல்லது ஸ்டிபேல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் அல்லது ஸ்டிபேல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் அல்லது ஸ்டிபேல் Today - Breaking & Trending Today

Investegate |Osirium Technologies Announcements | Osirium Technologies: Proposed Placing and Subscription & Notice of GM


 
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE OR ACQUIRE ANY SECURITIES IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA (UNLESS AN EXEMPTION UNDER THE RELEVANT SECURITIES LAWS IS AVAILABLE) OR IN ANY OTHER JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. ....

United States , District Of Columbia , United Kingdom , South Africa , City Of , Republic Of South Africa , Stephen Purdham , Rupert Hutton , Fred Walsh Richard , Simon Lee , David Guyatt , Simon Hember , Josh Royston Kieran Breheny , Company The Placing , Company Is Martin Kay , London Stock Exchange , Directors Of The Company , Regulatory Information Service , Financial Conduct Authority , Stifel Nicolaus Europe Limited , Stifel Nicolaus Europe , Company Secretary , European Union Withdrawal , Company The Ordinary , Commission Delegated Directive , Company Or Stifel ,

Investegate |Target H'care REIT Announcements | Target H'care REIT: Publication of a Prospectus and Circular


 
Capitalised terms used and not otherwise defined in this announcement have the meaning given to them in the Prospectus and/or the Circular.
 
Important Information
The person responsible for arranging for the release of this announcement on behalf of Target Healthcare REIT plc is Kenneth MacKenzie, Founder and Chief Executive of Target Fund Managers.
The information contained in this announcement is given at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment from time to time.
This announcement which has been prepared by, and is the sole responsibility of, the Directors of the Company, has been approved solely for the purposes of section 21 of the Financial Services and Markets Act 2000, as amended, ( FSMA ) by the Investment Manager, which is authorised and regulated by the Financial Conduct Authority. ....

United States , United Kingdom , South Africa , City Of , Republic Of South Africa , Republic Of Ireland , Mark Young , Claire Turvey , Richard Gotla , Kenneth Mackenzie , Mark Bloomfield , Charlotte Square , Dickson Minto , Rajpal Padam , Gordon Bland , Directors Of The Company , Eu Alternative Investment Fund Managers Directive , Company Secretary , European Union Withdrawal , European Union , Commission Delegated Directive , Company Or Stifel , None Of The Company , Part Of United Kingdom , London Stock Exchange , European Parliament ,

Investegate |MaxCyte, Inc. Announcements | MaxCyte, Inc.: MaxCyte Announces £40 million Subscription


About MaxCyte
MaxCyte is a world-leading provider of cell-engineering enabling technology and is responsible for helping to bring next-generation cell and gene-editing therapies to life. The Company s technology is deployed by leading drug developers worldwide, including all of the top ten global biopharmaceutical companies. MaxCyte licences have been granted for more than 140 cell therapy programmes, with more than 100 licensed for clinical use, and the Company has now entered into twelve clinical/commercial license partnerships with leading cell therapy and gene editing developers. MaxCyte was founded in 1998, is listed on the London Stock Exchange (LSE: MXCT, MXCL) and is headquartered in Gaithersburg, Maryland, US. For more information, visit www.maxcyte.com. ....

New York , United States , United Kingdom , South Africa , City Of , Republic Of South Africa , Nick Adams , Duncan Monteith Matthew Odowd , Doug Doerfler , Amanda Murphy , Mary Jane Elliott Chris Welsh , Messers Doerfler , Emma Earl Freddy Crossley , Panmure Gordon , Ron Holtz , Rupert Dearden , Company Enlarged Share Capital , Company Annual , Directors Of The Company , Company Nominated Adviser , Companies As Casdin Capital , Company Or Stifel , None Of The Company , Maxcyte Inc , London Stock Exchange , Eu Which Is Part Of United Kingdom ,